NASDAQ: GEMP Shareholder Notice: Investigation over Potential Wrongdoing at Gemphire Therapeutics Inc.
October 17, 2018 at 12:00 PM EDT
San Diego, CA -- (SBWIRE) -- 10/17/2018 -- An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Gemphire Therapeutics Inc.